SE425715B - Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom - Google Patents
Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdomInfo
- Publication number
- SE425715B SE425715B SE7514589A SE7514589A SE425715B SE 425715 B SE425715 B SE 425715B SE 7514589 A SE7514589 A SE 7514589A SE 7514589 A SE7514589 A SE 7514589A SE 425715 B SE425715 B SE 425715B
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- administration
- procedure
- amino acid
- liver disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/546,689 US3950529A (en) | 1975-02-03 | 1975-02-03 | Amino acid formulations for patients with liver disease and method of using same |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7514589L SE7514589L (sv) | 1976-08-04 |
SE425715B true SE425715B (sv) | 1982-11-01 |
Family
ID=24181564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7514589A SE425715B (sv) | 1975-02-03 | 1975-12-23 | Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom |
Country Status (16)
Country | Link |
---|---|
US (1) | US3950529A (sv) |
JP (1) | JPS51118839A (sv) |
BE (1) | BE838231A (sv) |
CA (1) | CA1050890A (sv) |
DE (1) | DE2556100A1 (sv) |
DK (1) | DK579875A (sv) |
FR (1) | FR2299023A1 (sv) |
GB (1) | GB1507951A (sv) |
IL (1) | IL48621A (sv) |
IN (1) | IN143663B (sv) |
IT (1) | IT1067502B (sv) |
NL (1) | NL169030C (sv) |
NZ (1) | NZ179655A (sv) |
PH (1) | PH11557A (sv) |
SE (1) | SE425715B (sv) |
ZA (1) | ZA7654B (sv) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4112085A (en) * | 1974-10-28 | 1978-09-05 | Morelle Jean V | Metallic compositions |
US4042688A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of providing high-protein nutrition by the oral administration of a predigested protein composition |
US4042687A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of treating obesity by the oral administration of a predigested protein composition |
US4053589A (en) * | 1975-11-24 | 1977-10-11 | Control Drug Inc. | Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism |
DE2636828A1 (de) * | 1976-08-16 | 1978-02-23 | Fresenius Chem Pharm Ind | L-amonosaeurengemische fuer die behandlung von leberinsuffizienz sowie die herstellung derartiger gemische |
DE2642768A1 (de) * | 1976-09-23 | 1978-03-30 | Fresenius Chem Pharm Ind | Essentielle und nicht essentielle l-aminosaeuren enthaltendes gemisch zur behandlung von leberinsuffizienz |
DE2750159C3 (de) * | 1977-11-09 | 1980-05-22 | Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen | Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung |
US4320146A (en) * | 1978-03-17 | 1982-03-16 | The Johns Hopkins University | Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids |
US4228099A (en) * | 1978-03-17 | 1980-10-14 | The Johns Hopkins University | Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders |
US4210637A (en) * | 1978-07-31 | 1980-07-01 | Massachusetts Institute Of Technology | Composition and method for suppressing appetite for calories as carbohydrates |
JPS5536457A (en) * | 1978-09-08 | 1980-03-14 | Ajinomoto Co Inc | Amino acid infusion |
IT1100677B (it) * | 1978-11-03 | 1985-09-28 | Boehringer Biochemia Srl | Formazione farmaceutica iniettabile a base di amminoacidi |
JPS568312A (en) * | 1979-07-03 | 1981-01-28 | Otsuka Pharmaceut Factory Inc | Amino acid pharmaceutical preparation |
JPS5668374A (en) * | 1979-11-08 | 1981-06-09 | Jun Sawada | Food composition for hepatic insufficiency |
DE2946563C2 (de) * | 1979-11-17 | 1987-04-30 | B. Braun Melsungen Ag, 3508 Melsungen | Aminosäurelösung zur parenteralen Infusion |
DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
US4438144A (en) | 1980-07-31 | 1984-03-20 | Blackburn George L | Amino acid preparation and therapy for treatment of stress and injury |
US4574085A (en) * | 1981-05-15 | 1986-03-04 | Baxter Travenol Laboratories, Inc. | Method for using dialysis solution containing glycerol |
CA1184499A (en) * | 1981-06-29 | 1985-03-26 | David C. Madsen | Nutritional composition for management of hepatic failure |
US4898879A (en) * | 1981-06-29 | 1990-02-06 | Baxter International Inc. | Nurtitional composition for management of hepatic failure |
JPS5835685U (ja) * | 1981-08-31 | 1983-03-08 | 三菱電機株式会社 | 電動圧縮機の支持装置 |
JPS5856177U (ja) * | 1981-10-13 | 1983-04-16 | ダイキン工業株式会社 | 圧縮機の取付装置 |
JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
US4497800A (en) * | 1982-07-06 | 1985-02-05 | Mead Johnson & Company | Stable liquid diet composition |
JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
FR2556594B1 (fr) * | 1983-12-20 | 1988-09-09 | Synthelabo | Solutions d'acides amines |
JPS6150917A (ja) * | 1984-08-20 | 1986-03-13 | Ajinomoto Co Inc | 抗アルコ−ル性肝障害組成物 |
US4687782A (en) * | 1984-12-10 | 1987-08-18 | Nutri-Fuels Systems, Inc. | Nutritional composition for enhancing skeletal muscle adaptation to exercise training |
US5763485A (en) * | 1985-09-12 | 1998-06-09 | Brigham And Women's Hospital | Method of treating catabolic, gut-associated pathological processes and impaired host defenses |
US5039704A (en) * | 1985-09-12 | 1991-08-13 | Brigham And Women's Hospital | Method of treating catabolic dysfunction |
US5607975A (en) * | 1985-09-12 | 1997-03-04 | Brigham And Women's Hospital | Method of treating catabolic, gut-associated pathological processes and impaired host defenses |
US4857555A (en) * | 1985-09-12 | 1989-08-15 | Brigham & Women's Hospital | Method of treating catabolic dysfunction |
US5397803A (en) * | 1985-09-12 | 1995-03-14 | Brigham And Women's Hospital | Use of glutamine to reduce rate of pathogenic microorganism infection |
JPH0667831B2 (ja) * | 1986-01-13 | 1994-08-31 | 森永乳業株式会社 | 肝物質合成機能障害改善用のアミノ酸組成物 |
US4859452A (en) * | 1986-01-17 | 1989-08-22 | Board Of Regents, The University Of Texas System | Methods for the reduction of difluoromethylornithine associated toxicity |
US5162373A (en) * | 1986-01-17 | 1992-11-10 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
JP2599593B2 (ja) * | 1986-06-26 | 1997-04-09 | 株式会社 大塚製薬工場 | 腎不全用アミノ酸輸液 |
JPS6314728A (ja) * | 1986-07-03 | 1988-01-21 | Zeria Shinyaku Kogyo Kk | 肝障害の予防、治療剤 |
US5248688A (en) * | 1986-09-10 | 1993-09-28 | Dudrick Medical Research Fund I, Ltd. | Method and substrate composition for treating atherosclerosis |
US5032608A (en) * | 1986-09-10 | 1991-07-16 | Dudrick Stanley J | Method and substrate composition for treating atherosclerosis |
GB2199243A (en) * | 1986-09-17 | 1988-07-06 | Natural Vitality Ltd | Pharmaceutical compositions comprising ornithine and arginine |
US4857320A (en) * | 1987-02-19 | 1989-08-15 | Monsanto Company | Method of enhancing the solubility of tissue plasminogen activator |
US5639731A (en) * | 1987-05-22 | 1997-06-17 | Pripps Bryggerier Ab | Amino acids for the preparation of a beverage |
WO1988009132A1 (en) * | 1987-05-22 | 1988-12-01 | Ab Pripps Bryggerier | Use of amino acids for the preparation of a beverage |
US4868114A (en) * | 1987-08-05 | 1989-09-19 | Regents Of The University Of Minnesota | Method for elevating glutathione levels |
JPH0277550A (ja) * | 1988-09-12 | 1990-03-16 | Furukawa Alum Co Ltd | 成形加工用快削アルミニウム合金とその製造方法 |
US4988724A (en) * | 1988-12-09 | 1991-01-29 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
US5189025A (en) * | 1988-12-09 | 1993-02-23 | Board Of Regenets, The University Of Texas System | Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions |
DE3916903A1 (de) * | 1989-05-24 | 1991-02-28 | Leopold Pharma Gmbh | Waessrige zusammensetzung fuer die parenterale ernaehrung |
US5179080A (en) * | 1989-08-31 | 1993-01-12 | Clinical Homecare, Corp. | Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease |
US5576351A (en) * | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
US5286739A (en) * | 1991-09-27 | 1994-02-15 | Board Of Regents, University Of Texas System | Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
DE4134723C1 (sv) * | 1991-10-21 | 1993-02-11 | Pfrimmer Kabi Gmbh & Co Kg, 8520 Erlangen, De | |
US5266685A (en) * | 1992-05-05 | 1993-11-30 | Grain Processing Corporation | Non-bitter protein hydrolyzates |
JPH06109286A (ja) * | 1992-09-28 | 1994-04-19 | Daikin Ind Ltd | 圧縮機の取付構造 |
US5292722A (en) * | 1992-11-06 | 1994-03-08 | Brigham And Women's Hospital | Intravenous solution that diminishes body protein loss |
WO1994016740A1 (en) * | 1993-01-29 | 1994-08-04 | Brigham And Women's Hospital | The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury |
US5571783A (en) * | 1993-03-09 | 1996-11-05 | Clintec Nutrition Company | Composition and method for treating patients with hepatic disease |
US5449679A (en) * | 1994-07-29 | 1995-09-12 | Leonard; Robert J. | Process and products for reducing biological fluid levels of a lipid soluble waste |
US20040022827A1 (en) * | 1997-09-30 | 2004-02-05 | Chugai Seiyaku Kabusiki Kaisha | Remedy for hepatopathy |
FR2800243B1 (fr) | 1999-11-02 | 2002-01-18 | Royal Canin Sa | Composition alimentaire ou veterinaire pour carnivore domestique contenant de la tyrosine libre pour prevenir les anomalies de pigmentation du pelage |
US20010014442A1 (en) * | 2000-02-09 | 2001-08-16 | Morris James G. | Essential constituent and method of use for maintaining hair coloration or reversing hair discoloration |
WO2002060431A1 (fr) * | 2001-01-30 | 2002-08-08 | Ajinomoto Co., Inc. | Medicaments therapeutiques/prophylactiques contre des maladies inflammatoires |
ATE441409T1 (de) * | 2001-03-15 | 2009-09-15 | Riken | Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber |
US20020193342A1 (en) * | 2001-05-09 | 2002-12-19 | Hamman John P. | Modifying undesirable tastes |
US20040219188A1 (en) * | 2003-05-02 | 2004-11-04 | Comer Gail M. | Composition and methods for nutritional management of patients with hepatic disease |
US20070031534A1 (en) * | 2004-02-27 | 2007-02-08 | Hajime Tsujimoto | Pet food for reducing food allergy reactions |
ES2537974T3 (es) | 2004-11-26 | 2015-06-16 | Ucl Business Plc | Composiciones que comprenden ornitina y fenilacetato o fenilbutirato para el tratamiento de la encefalopatía hepática |
EP1829540A4 (en) * | 2004-12-10 | 2008-04-02 | Ajinomoto Kk | COMPOSITION FOR THE PREVENTION / TREATMENT OF LIVER DISEASES |
KR20070112811A (ko) | 2005-03-21 | 2007-11-27 | 아보트 러보러터리즈 | 포도당내성을 개선시키기 위한 아미노산 조성물 |
WO2010115055A1 (en) | 2009-04-03 | 2010-10-07 | Ocera Therapeutics, Inc. | L-ornithine phenyl acetate and methods of making thereof |
DK2440200T3 (en) | 2009-06-08 | 2014-12-08 | Ucl Business Plc | Treatment of portal hypertension in the application of l-ornithinphenylacetat |
NZ609191A (en) | 2010-10-06 | 2015-06-26 | Ocera Therapeutics Inc | Methods of making l-ornithine phenyl acetate |
US11389663B2 (en) | 2011-04-01 | 2022-07-19 | Bioregentech, Inc. | Laser assisted wound healing protocol and system |
US11730760B2 (en) | 2011-04-01 | 2023-08-22 | The Bioregentech Institute, Inc. | Laser assisted wound healing protocol and system |
KR20160013020A (ko) * | 2013-04-16 | 2016-02-03 | 몰레큘러 시스템즈, 리미티드 | 레이저 보조 치주 조직 및 뼈 재생 프로토콜 |
BR112017010761B1 (pt) | 2014-11-24 | 2022-10-18 | Ucl Business Plc | Tratamento de doenças associadas à ativação de célula estrelada hepática com o uso de terapias de redução de amônia |
WO2017031131A1 (en) | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
WO2018089954A1 (en) | 2016-11-10 | 2018-05-17 | BioRegentech | Laser assisted wound healing protocol and system |
US11654293B2 (en) | 2016-11-10 | 2023-05-23 | The Bioregentech Institute, Inc. | Laser assisted wound healing protocol and system |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CA3063134A1 (en) | 2017-05-11 | 2018-11-15 | Ocera Therapeutics, Inc. | Processes of making l-ornithine phenylacetate |
PE20200747A1 (es) | 2017-08-14 | 2020-07-24 | Axcella Health Inc | Composiciones de aminoacidos para el tratamiento de enfermedad hepatica |
MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2666013A (en) * | 1950-08-25 | 1954-01-12 | Jr Edgar A Ferguson | Pruritus therapy |
US3256095A (en) * | 1962-10-17 | 1966-06-14 | Union Carbide Corp | Nutritional utilization of amino acid amides and acid salts thereof |
DE1667887C2 (de) * | 1968-02-09 | 1978-09-28 | Knauff, Hans Georg, Prof. Dr., 3551 Dagobertshausen | Aminosäurelösung zur parenteralen Infusion |
GB1256162A (en) * | 1968-08-16 | 1971-12-08 | Braun Fa B | Improvements in and relating to liquid products for intravenous administration |
US3697287A (en) * | 1969-01-28 | 1972-10-10 | Morton Norwich Products Inc | Amino acid food composition |
US3764703A (en) * | 1969-11-07 | 1973-10-09 | Astra Ab | Amino acid mixture for use in treatment of uremic conditions |
US3773930A (en) * | 1971-03-23 | 1973-11-20 | Johnson & Johnson | Amino acid composition |
US3832465A (en) * | 1971-12-09 | 1974-08-27 | H Ghadimi | Injectable amino acid composition commensurate to the anabolic need of the body and method of using same |
GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
-
1975
- 1975-02-03 US US05/546,689 patent/US3950529A/en not_active Expired - Lifetime
- 1975-12-08 IL IL48621A patent/IL48621A/xx unknown
- 1975-12-10 IN IN2319/CAL/75A patent/IN143663B/en unknown
- 1975-12-12 DE DE19752556100 patent/DE2556100A1/de active Granted
- 1975-12-19 DK DK579875A patent/DK579875A/da unknown
- 1975-12-23 NZ NZ179655A patent/NZ179655A/xx unknown
- 1975-12-23 SE SE7514589A patent/SE425715B/sv unknown
- 1975-12-30 NL NLAANVRAGE7515199,A patent/NL169030C/xx not_active IP Right Cessation
-
1976
- 1976-01-06 ZA ZA54A patent/ZA7654B/xx unknown
- 1976-01-09 IT IT19138/76A patent/IT1067502B/it active
- 1976-01-14 CA CA243,493A patent/CA1050890A/en not_active Expired
- 1976-01-15 GB GB1621/76A patent/GB1507951A/en not_active Expired
- 1976-01-19 JP JP51005364A patent/JPS51118839A/ja active Granted
- 1976-01-21 PH PH18004A patent/PH11557A/en unknown
- 1976-02-02 FR FR7602778*[A patent/FR2299023A1/fr active Granted
- 1976-02-03 BE BE164062A patent/BE838231A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NL7515199A (nl) | 1976-08-05 |
US3950529A (en) | 1976-04-13 |
IN143663B (sv) | 1978-01-14 |
FR2299023A1 (fr) | 1976-08-27 |
PH11557A (en) | 1978-03-31 |
NL169030B (nl) | 1982-01-04 |
IT1067502B (it) | 1985-03-16 |
GB1507951A (en) | 1978-04-19 |
JPS5627493B2 (sv) | 1981-06-25 |
CA1050890A (en) | 1979-03-20 |
DK579875A (da) | 1976-08-04 |
BE838231A (fr) | 1976-05-28 |
FR2299023B1 (sv) | 1979-09-28 |
IL48621A (en) | 1978-09-29 |
NZ179655A (en) | 1978-03-06 |
JPS51118839A (en) | 1976-10-19 |
DE2556100A1 (de) | 1976-08-05 |
AU1024076A (en) | 1977-07-21 |
IL48621A0 (en) | 1976-02-29 |
SE7514589L (sv) | 1976-08-04 |
NL169030C (nl) | 1982-06-01 |
DE2556100C2 (sv) | 1987-06-19 |
ZA7654B (en) | 1977-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE425715B (sv) | Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom | |
SE444809B (sv) | Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar | |
NO150397C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive acylderivater av aminosyrer | |
NO784397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater | |
NO784211L (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater | |
NO784231L (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater | |
SE7609316L (sv) | Medicinsk inhalationsapparat for behandling av sjukdomar i andningsvegaran | |
NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
NO145382C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater. | |
SE429961B (sv) | Forfarande for framstellning av mjolksyra | |
SE7601204L (sv) | Terapeutiskt system for administrering av skopolamin transdermalt | |
NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
NO146865C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater | |
NO780214L (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive aminoalkoksyfenylderivater | |
SE7701187L (sv) | Nya piperazinderivat och sett att framstella desamma | |
SE411671B (sv) | Forfarande for framstellning av tripeptidderivat med terapeutisk verkan | |
SE7600343L (sv) | Forfarande for framstellning av ferrocenderivat med terapeutisk verkan | |
NO784325L (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater | |
NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
NO142525C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive isotiourinstoff-forbindelser | |
SE7608538L (sv) | Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan | |
SE7608115L (sv) | Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan | |
AT342761B (de) | Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung | |
NO146138C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoesyrederivater | |
SE7607026L (sv) | Forfarande for framstellning av 5-alkylpikolinsyra |